筛查氟嘧啶类药物治疗患者的二氢嘧啶脱氢酶（DPD）缺乏症：监管变化的影响

{"title":"筛查氟嘧啶类药物治疗患者的二氢嘧啶脱氢酶（DPD）缺乏症：监管变化的影响","authors":"C. Calderon, G. Maillan, E. Deluche, N. Picard","doi":"10.1016/j.phacli.2024.04.243","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":508818,"journal":{"name":"Le Pharmacien Clinicien","volume":"61 12","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Dépistage du déficit en dihydropyrimidine déshydrogénase (DPD) chez les patients traites par fluoropyrimidines : impact de l’évolution de la réglementation\",\"authors\":\"C. Calderon, G. Maillan, E. Deluche, N. Picard\",\"doi\":\"10.1016/j.phacli.2024.04.243\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":508818,\"journal\":{\"name\":\"Le Pharmacien Clinicien\",\"volume\":\"61 12\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Le Pharmacien Clinicien\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.phacli.2024.04.243\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Le Pharmacien Clinicien","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.phacli.2024.04.243","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}